Summary
The Centers for Disease Control and Prevention (CDC) issued a Notice of Intent to award a sole-source contract to procure and deliver lateral flow test results from persons receiving integrase inhibitor–based long‑acting PrEP, seeking a provider to collect and manage dried blood spot specimens. The notice identifies the Dallas County Health Sexual Health Clinic as the only currently identified source with the needed IRB-approved protocol experience and ability to recruit participants (target ~50). The opportunity is a presolicitation/notice of intent (not a grant), is active on SAM.gov, and requests any quotations/responses be emailed to the contract specialist by the stated response date.